Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cheminor Drugs Ltd.

Division of Dr. Reddy's Laboratories Ltd.

Latest From Cheminor Drugs Ltd.

People In Brief

Reddy’s CEO adds chairman title; NattoPharma names Anderson sales and marketing SVP; Cuss takes on CSO post at Bristol-Myers Squibb; Rodgers and Hall swap House subcommittee seats; Life Extension hires product development leader; more People In Brief.

Consumer United States

People In Brief

Reddy’s CEO adds chairman title; NattoPharma names Anderson sales and marketing SVP; Cuss takes on CSO post at Bristol-Myers Squibb; Rodgers and Hall swap House subcommittee seats; Life Extension hires product development leader; more People In Brief.

Consumer United States

AstraZeneca: Bridging the Prilosec Earnings Gap

AstraZeneca appears to have navigated the integration process without much of the turmoil seen in other mergers. As part of that integration, the company created a new, centralized sales and marketing infrastructure intended to transform two mid-size European companies into a commercial global power. That new organization will soon confront the company's most immediate challenge: dealing with the genericization of the world's biggest drug, Prilosec. Whether AstraZeneca can meet that challenge will turn largely on the extent to which two late-stage drug candidates, Nexium and Crestor, can fill the Prilosec void. They'll require a commercialization effort far beyond that attempted by the former Astra or Zeneca.
BioPharmaceutical Strategy
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register